Dx assays Pte. Ltd.

Dx assays Pte. Ltd. is a pioneering biotechnology research company established in 2008, marking its position as the first commercial developer of molecular diagnostic assays in Singapore. Specializing in Nucleic Acid-based Test (NAT) Development, Dx assays Pte. Ltd. offers highly customizable services without restrictions on chemistry or instrumentation platforms. The company focuses on meeting client requirements across various areas, including infectious diseases, oncology, genetic testing, and companion diagnostics, tailoring its services to fulfill diverse business needs.

Dx assays Pte. Ltd. provides a suite of key services divided into five major areas: Molecular Diagnostics, Product Enhancement Services, Verification & Validation, Companion Diagnostics, and Laboratory Developed Tests. These services are designed to support and enhance the diagnostic capabilities of its clients, ensuring accuracy and reliability in molecular testing. Dx assays Pte. Ltd. is committed to advancing the field of biotechnology through innovative solutions and comprehensive service offerings.

With a focus on quality and innovation, Dx assays Pte. Ltd. continues to be a leader in the biotechnology sector. The company’s dedication to Nucleic Acid-based Test development ensures that it remains at the forefront of diagnostic advancements. We invite the manager of Dx assays Pte. Ltd. to create a customized and exclusive company showcase and product listing on our platform to further highlight its expertise and offerings.